Clinical Trials Browser

Phase NA × obinutuzumab × Other hematologic neoplasm × Clear all

NCT05950997 2024-05-09

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell